Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:25 PM
Ignite Modification Date: 2025-12-25 @ 3:55 PM
NCT ID: NCT05036668
Description: None
Frequency Threshold: 5
Time Frame: Adverse events were reported from oral administration of ABO809 up to a maximum duration of 56 days.
Study: NCT05036668
Study Brief: Study of Efficacy and Safety of ABO809 in Healthy Participants
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ABO809 1x10^4 CE - Cohort 1 ABO809 single oral dose of 1x10\^4 oocysts. 0 None 0 10 10 10 View
ABO809 1x10^6 CE-Cohort 2 ABO809 single oral dose of 1x10\^6 oocysts. 0 None 0 10 9 10 View
ABO809 1x10^6 CE-Cohort 3 ABO809 single oral dose of 1x10\^6 oocysts. 0 None 0 10 9 10 View
ABO809 1x10^6 CE - Cohorts 2 and 3 ABO809 single oral dose of 1x10\^6 oocysts. 0 None 0 20 18 20 View
Total Total 0 None 0 30 28 30 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Palpitations SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (25.1) View
Tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (25.1) View
Abdominal discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Abdominal tenderness SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Defaecation urgency SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Flatulence SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Haematochezia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Proctalgia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Rectal tenesmus SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View
Chills SYSTEMATIC_ASSESSMENT General disorders MedDRA (25.1) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (25.1) View
Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (25.1) View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA (25.1) View
Aspartate aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (25.1) View
Blood creatine phosphokinase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (25.1) View
Body temperature increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (25.1) View
Heart rate increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (25.1) View
Lipase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (25.1) View
Occult blood SYSTEMATIC_ASSESSMENT Investigations MedDRA (25.1) View
Occult blood positive SYSTEMATIC_ASSESSMENT Investigations MedDRA (25.1) View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (25.1) View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (25.1) View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (25.1) View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (25.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (25.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (25.1) View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (25.1) View
Chromaturia SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (25.1) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Nasal congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Oropharyngeal pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Rhinorrhoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Sneezing SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Night sweats SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (25.1) View
Hot flush SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (25.1) View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (25.1) View
Orthostatic hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (25.1) View